Economic burden of cardiovascular diseases in Serbia

Background/Aim. Cardiovascular disease imposes a burden to society in terms of mortality, morbidity and economic losses. The aim of this study was to estimate the economic burden of cardiovascular disease in Serbia in 2009 from the perspective of the society. Methods. For the purpose of the...

Full description

Bibliographic Details
Main Authors: Lakić Dragana, Tasić Ljiljana, Kos Mitja
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2014-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2014/0042-84501402137L.pdf
id doaj-b21c30df812e4277859657e698e49e47
record_format Article
spelling doaj-b21c30df812e4277859657e698e49e472020-11-25T01:32:06ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502014-01-0171213714310.2298/VSP1402137L0042-84501402137LEconomic burden of cardiovascular diseases in SerbiaLakić Dragana0Tasić Ljiljana1Kos Mitja2Faculty of Pharmacy, Department of Social Pharmacy and Pharmaceutical Legislation, BelgradeFaculty of Pharmacy, Department of Social Pharmacy and Pharmaceutical Legislation, BelgradeUniversity of Ljubljana, Faculty of Pharmacy, Chair for Social Pharmacy, Ljubljana, SloveniaBackground/Aim. Cardiovascular disease imposes a burden to society in terms of mortality, morbidity and economic losses. The aim of this study was to estimate the economic burden of cardiovascular disease in Serbia in 2009 from the perspective of the society. Methods. For the purpose of the study cardiovascular disease was defined by the International Classification of Diseases, 10th revision, as the following diagnosis: hypertension, coronary heart disease, cardiomyopathy, heart failure and cerebrovascular disease. The prevalence, top-down method was used to quantify the annual cardiovascular costs. Productivity losses were estimated using the human capital approach and the friction cost method. A discount rate of 5% was used to convert all future lifetime earnings into the present value. Results. The total direct costs of cardiovascular disease in 2009 were € 400 million. The results showed that more than half a million working days were lost due to incapacity resulting from cardiovascular diseases, yielding the € 113.9 million. The majority of total costs (€ 514.3 million) were for: medication (29.94%), hospital days (28.97%) and hospital inpatient care - surgical and diagnostic interventions (17.84%). The results were robust to a change in 20% of volume or the unit price of all direct and indirect cost and to discount rate 2% and 10%. Conclusions. The total cardiovascular disease costs in 2009 represented approximately 1.8% of the Serbian gross domestic product. The results of the study would be valuable to health policy makers to bridge the gap between invested resources and needs, in order to improve cardiovascular disease outcomes. [Projekat Ministarstva nauke Republike Srbije, br. 175035]http://www.doiserbia.nb.rs/img/doi/0042-8450/2014/0042-84501402137L.pdfcardiovascular diseaseshealth care costsSerbia
collection DOAJ
language English
format Article
sources DOAJ
author Lakić Dragana
Tasić Ljiljana
Kos Mitja
spellingShingle Lakić Dragana
Tasić Ljiljana
Kos Mitja
Economic burden of cardiovascular diseases in Serbia
Vojnosanitetski Pregled
cardiovascular diseases
health care costs
Serbia
author_facet Lakić Dragana
Tasić Ljiljana
Kos Mitja
author_sort Lakić Dragana
title Economic burden of cardiovascular diseases in Serbia
title_short Economic burden of cardiovascular diseases in Serbia
title_full Economic burden of cardiovascular diseases in Serbia
title_fullStr Economic burden of cardiovascular diseases in Serbia
title_full_unstemmed Economic burden of cardiovascular diseases in Serbia
title_sort economic burden of cardiovascular diseases in serbia
publisher Military Health Department, Ministry of Defance, Serbia
series Vojnosanitetski Pregled
issn 0042-8450
publishDate 2014-01-01
description Background/Aim. Cardiovascular disease imposes a burden to society in terms of mortality, morbidity and economic losses. The aim of this study was to estimate the economic burden of cardiovascular disease in Serbia in 2009 from the perspective of the society. Methods. For the purpose of the study cardiovascular disease was defined by the International Classification of Diseases, 10th revision, as the following diagnosis: hypertension, coronary heart disease, cardiomyopathy, heart failure and cerebrovascular disease. The prevalence, top-down method was used to quantify the annual cardiovascular costs. Productivity losses were estimated using the human capital approach and the friction cost method. A discount rate of 5% was used to convert all future lifetime earnings into the present value. Results. The total direct costs of cardiovascular disease in 2009 were € 400 million. The results showed that more than half a million working days were lost due to incapacity resulting from cardiovascular diseases, yielding the € 113.9 million. The majority of total costs (€ 514.3 million) were for: medication (29.94%), hospital days (28.97%) and hospital inpatient care - surgical and diagnostic interventions (17.84%). The results were robust to a change in 20% of volume or the unit price of all direct and indirect cost and to discount rate 2% and 10%. Conclusions. The total cardiovascular disease costs in 2009 represented approximately 1.8% of the Serbian gross domestic product. The results of the study would be valuable to health policy makers to bridge the gap between invested resources and needs, in order to improve cardiovascular disease outcomes. [Projekat Ministarstva nauke Republike Srbije, br. 175035]
topic cardiovascular diseases
health care costs
Serbia
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2014/0042-84501402137L.pdf
work_keys_str_mv AT lakicdragana economicburdenofcardiovasculardiseasesinserbia
AT tasicljiljana economicburdenofcardiovasculardiseasesinserbia
AT kosmitja economicburdenofcardiovasculardiseasesinserbia
_version_ 1725083247044460544